SMMT
$16.76+0.42%
as of close, Oct 2, 2026
☾ AH $16.76 +0.42%
Summit Therapeutics Inc. Common StockStock · Health CareNasdaq Composite 0.03%Russell 1000 0.002%US Stock Market 0.002%Russell 3000 0.002%
SMMT financial statements
The full income statement, balance sheet, and cash-flow statement for Summit Therapeutics Inc. Common Stock (SMMT), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.
Shares outstanding (point-in-time)
2024-06 724.5M2024-09 737.4M2024-12 737.7M2025-03 742.7M2025-06 742.8M2025-09 744.4M2025-12 775.4M2026-03 776.2M2026-06 797.7M+10.1% over 8 periods
SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.
As-reported fiscal years.
| Line item | Trend | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Income Statement | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Revenue | — | 0.00 | 0.00-100.0% | 705K-61.0% | 1.81M+110.3% | |
| 1.09B+384.3% | 226M-62.9% | 610M+599.1% | 87.2M-20.0% | 109M+48.5% | ||
| Research & development | 538M+256.6% | 151M+153.5% | 59.5M+14.4% | 52.0M-39.1% | 85.4M+60.2% | |
| Selling, general & administrative | 557M+824.6% | 60.2M+105.8% | 29.3M+9.4% | 26.7M+13.3% | 23.6M+22.8% | |
| General & administrative | 557M+824.6% | 60.2M+105.8% | 29.3M+9.4% | 26.7M+13.3% | 23.6M+22.8% | |
| Amortization of intangibles | — | 0.00 | 0.00-100.0% | 914K-10.1% | 1.02M-18.6% | |
| Operating income | — | -226M+62.9% | -610M-745.7% | -72.1M+16.4% | -86.2M-62.0% | |
| Interest expense | 0.00-100.0% | 8.69M-47.2% | 16.5M+274.0% | 4.40M+1718.6% | 242K-5.1% | |
| Interest & investment income | — | — | — | 1.51M | 0.00-100.0% | |
| Other non-operating income | 14.8M | 0.00+100.0% | -252K-182.9% | 304K+112.6% | -2.42M-953.7% | |
| Pre-tax income | -1.08B-387.8% | -221M+64.0% | -615M-680.5% | -78.8M+11.1% | -88.6M-67.5% | |
| Income tax | 0.00 | 0.00 | 0.00 | — | 0.00+100.0% | |
| Net income | -1.08B-387.8% | -221M+64.0% | -615M-680.5% | -78.8M+11.1% | -88.6M-68.1% | |
| -$1.44-364.5% | -$0.31+68.7% | -$0.99-141.5% | -$0.41+38.8% | -$0.67+11.8% | ||
| EPS (basic) | -$1.44-364.5% | -$0.31+68.7% | -$0.99-141.5% | -$0.41+38.8% | -$0.67+11.8% | |
| Weighted-avg shares (basic) | 748M+4.1% | 719M+16.0% | 620M+220.5% | 193M+46.8% | 132M+89.5% | |
| Weighted-avg shares (diluted) | 748M+4.1% | 719M+16.0% | 620M+220.5% | 193M+46.8% | 132M+89.5% | |
| Balance Sheet | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| 720M+70.0% | 424M+123.4% | 190M-71.1% | 657M+574.9% | 97.3M+11.0% | ||
| Cash & equivalents | 225M+114.8% | 105M+46.8% | 71.4M-79.5% | 349M+385.6% | 71.8M+8.1% | |
| Short-term investments | 488M+58.8% | 307M+167.8% | 115M | 0.00 | — | |
| Cash & short-term investments | — | — | 186M | — | — | |
| Accounts receivable | — | — | 0.00-100.0% | 349K-76.2% | 1.46M+342.3% | |
| Prepaid expenses | 6.54M-41.0% | 11.1M+322.4% | 2.62M+74.3% | 1.50M-79.0% | 7.16M-25.0% | |
| Other current assets | — | — | 181K-62.8% | 486K-59.5% | 1.20M-21.1% | |
| 751M+72.5% | 436M+114.6% | 203M-69.4% | 664M+485.8% | 113M+10.6% | ||
| Property, plant & equipment | 1.06M+316.9% | 254K+24.5% | 204K-77.5% | 906K+30.5% | 694K-4.3% | |
| Operating lease right-of-use | 20.6M+188.6% | 7.14M+21.9% | 5.86M+40.3% | 4.17M+49.6% | 2.79M+403.6% | |
| Goodwill | 2.00M+7.3% | 1.86M-1.5% | 1.89M+5.3% | 1.80M-10.5% | 2.01M-1.0% | |
| Intangible assets | — | 0.00 | 0.00 | 0.00-100.0% | 10.4M-9.7% | |
| Other non-current assets | 7.21M+182.8% | 2.55M-41.0% | 4.32M+649.0% | 577K+239.4% | 170K | |
| 73.0M+74.9% | 41.7M+104.5% | 20.4M-47.4% | 38.8M+51.4% | 25.6M+28.8% | ||
| Accounts payable | 20.3M+337.7% | 4.64M+73.8% | 2.67M+651.3% | 355K-91.9% | 4.37M-28.8% | |
| Accrued liabilities | 32.1M+64.2% | 19.6M+122.6% | 8.78M-17.6% | 10.7M+48.2% | 7.20M+119.6% | |
| Deferred revenue | — | — | — | 0.00-100.0% | 7.94M-5.1% | |
| Current lease liability | 3.39M-10.0% | 3.77M+34.0% | 2.81M+66.2% | 1.69M+54.9% | 1.09M+179.7% | |
| Other current liabilities | 2.28M+27.0% | 1.80M+150.6% | 717K+8.3% | 662K-26.2% | 897K+23.0% | |
| 92.3M+97.2% | 46.8M-62.6% | 125M-76.7% | 538M+1686.4% | 30.1M+30.6% | ||
| Deferred revenue (non-current) | — | — | — | 0.00 | 0.00-100.0% | |
| Non-current lease liability | 17.5M+406.9% | 3.45M+5.0% | 3.29M+19.1% | 2.76M+63.4% | 1.69M+2154.7% | |
| Operating lease liability (total) | 20.9M+189.4% | 7.22M+18.3% | 6.10M+37.0% | 4.45M+60.1% | 2.78M+498.3% | |
| Other non-current liabilities | 1.83M+12.4% | 1.63M+4.4% | 1.56M+9.3% | 1.43M-48.5% | 2.78M+10.6% | |
| 659M+69.5% | 389M+400.4% | 77.7M-38.7% | 127M+52.1% | 83.3M+4.8% | ||
| Preferred stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Common stock | 7.75M+5.1% | 7.38M+5.1% | 7.02M+232.6% | 2.11M+115.3% | 980K+18.6% | |
| Additional paid-in capital | 2.95B+84.4% | 1.60B+49.9% | 1.07B+111.3% | 505M+31.4% | 384M+30.9% | |
| Retained earnings | -2.29B-88.9% | -1.21B-22.3% | -993M-162.5% | -378M-26.3% | -300M-42.0% | |
| Accumulated other comprehensive income | -2.54M-11.2% | -2.29M+6.7% | -2.45M-29.3% | -1.89M+13.8% | -2.20M+42.1% | |
| Total liabilities & equity | 751M+72.5% | 436M+114.6% | 203M-69.4% | 664M+485.8% | 113M+10.6% | |
| Common shares issued | 775M+5.1% | 738M+5.1% | 702M+232.4% | 211M+115.3% | 98.0M+18.7% | |
| Common shares outstanding | 775M+5.1% | 738M+5.1% | 702M+232.4% | 211M+115.3% | 98.0M+18.7% | |
| Shares outstanding (cover) | 775M+5.1% | 738M+5.1% | 702M+0.6% | 698M+611.0% | 98.1M+18.3% | |
| Cash Flow | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| -323M-127.2% | -142M-85.1% | -76.8M-84.6% | -41.6M+42.7% | -72.6M-50.9% | ||
| Depreciation & amortization | 146K+64.0% | 89.0K-55.1% | 198K-84.3% | 1.26M-6.2% | 1.35M-13.2% | |
| Intangible amortization | — | 0.00 | 0.00-100.0% | 914K-10.1% | 1.02M-18.6% | |
| Share-based compensation | 732M+1336.7% | 51.0M+261.4% | 14.1M+18.1% | 11.9M-6.7% | 12.8M+625.0% | |
| Deferred income taxes | — | — | — | — | 0.00 | |
| Change in receivables | — | 0.00+100.0% | -359K+63.2% | -975K-185.7% | 1.14M+636.8% | |
| Change in payables | 15.3M+659.5% | 2.02M-11.0% | 2.26M+154.8% | -4.13M-141.5% | -1.71M-204.2% | |
| -174M+15.1% | -205M+65.1% | -588M-94094.6% | -624K-103.9% | -306K+27.3% | ||
| Capital expenditure | 657K+372.7% | 139K+8.6% | 128K-79.5% | 624K+103.9% | 306K-27.3% | |
| Free cash flow | -324M-127.5% | -142M-85.0% | -76.9M-82.2% | -42.2M+42.1% | -72.9M-50.2% | |
| Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Proceeds from sale of PP&E | 0.00 | 0.00-100.0% | 226K | 0.00 | — | |
| 618M+62.0% | 381M+340.7% | 86.5M-86.1% | 620M+696.0% | 77.9M+54.1% | ||
| Long-term debt issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long-term debt repaid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Common stock issued | 0.00 | 0.00-100.0% | 105M+4.7% | 100M+33.3% | 75.0M+50.0% | |
| Common stock repurchased | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividends paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| FX effect on cash | — | — | — | — | 351K-36.9% | |
| Net change in cash | 120M+256.6% | 33.8M+105.8% | -577M-200.1% | 577M+10633.5% | 5.37M+108.7% | |
| Interest paid | 0.00-100.0% | 8.81M-17.3% | 10.7M+2353.9% | 434K+410.6% | 85.0K | |
| Income taxes paid | 0.00 | 0.00-100.0% | 52.0K | 0.00-100.0% | 7.00K+110.0% | |
| Valuation Ratios | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Market cap | 13.6B+3.0% | 13.2B+619.7% | 1.83B+113.8% | 856M+224.2% | 264M-32.3% | |
| P/S | — | — | — | 895.0×+513.4% | 145.9×-67.8% | |
| P/B | 20.6×-39.2% | 33.9×+84.0% | 18.4×+186.6% | 6.4×+102.6% | 3.2×-35.4% | |
| Source filing | 10-K | 10-K | 10-K | 10-K | 10-K/A |
About this data
Source: SMMT’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all SMMT filings on SEC EDGAR → Not investment advice.